These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23049448)

  • 21. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data.
    Wallace DF; Subramaniam VN
    Genet Med; 2016 Jun; 18(6):618-26. PubMed ID: 26633544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload.
    Badar S; Busti F; Ferrarini A; Xumerle L; Bozzini P; Capelli P; Pozzi-Mucelli R; Campostrini N; De Matteis G; Marin Vargas S; Giorgetti A; Delledonne M; Olivieri O; Girelli D
    Am J Hematol; 2016 Jun; 91(4):420-5. PubMed ID: 26799139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
    Kaneko Y; Miyajima H; Piperno A; Tomosugi N; Hayashi H; Morotomi N; Tsuchida K; Ikeda T; Ishikawa A; Ota Y; Wakusawa S; Yoshioka K; Kono S; Pelucchi S; Hattori A; Tatsumi Y; Okada T; Yamagishi M
    J Gastroenterol; 2010 Nov; 45(11):1163-71. PubMed ID: 20533066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress in iron metabolism research].
    Kawabata H
    Rinsho Ketsueki; 2017; 58(10):1864-1871. PubMed ID: 28978826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appropriate Clinical Genetic Testing of Hemochromatosis Type 2-4, Including Ferroportin Disease.
    Kowdley DS; Kowdley KV
    Appl Clin Genet; 2021; 14():353-361. PubMed ID: 34413666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-generation sequencing of hereditary hemochromatosis-related genes: Novel likely pathogenic variants found in the Portuguese population.
    Faria R; Silva B; Silva C; Loureiro P; Queiroz A; Fraga S; Esteves J; Mendes D; Fleming R; Vieira L; Gonçalves J; Faustino P
    Blood Cells Mol Dis; 2016 Oct; 61():10-5. PubMed ID: 27667161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variable expressivity of HJV related hemochromatosis: "Juvenile" hemochromatosis?
    Hamdi-Rozé H; Ben Ali Z; Ropert M; Detivaud L; Aggoune S; Simon D; Pelletier G; Deugnier Y; David V; Bardou-Jacquet E
    Blood Cells Mol Dis; 2019 Feb; 74():30-33. PubMed ID: 30389309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron chelators reverse organ damage in type 4B hereditary hemochromatosis: Case reports.
    Wu LY; Song ZY; Li QH; Mou LJ; Yu YY; Shen SS; Song XX
    Medicine (Baltimore); 2021 Apr; 100(13):e25258. PubMed ID: 33787609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.
    Radio FC; Majore S; Aurizi C; Sorge F; Biolcati G; Bernabini S; Giotti I; Torricelli F; Giannarelli D; De Bernardo C; Grammatico P
    Blood Cells Mol Dis; 2015 Jun; 55(1):71-5. PubMed ID: 25976471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.
    Delima RD; Chua AC; Tirnitz-Parker JE; Gan EK; Croft KD; Graham RM; Olynyk JK; Trinder D
    Hepatology; 2012 Aug; 56(2):585-93. PubMed ID: 22383097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hereditary and acquired iron overload].
    de Korwin JD
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causes of iron overload in blood donors - a clinical study.
    Laursen AH; Bjerrum OW; Friis-Hansen L; Hansen TO; Marott JL; Magnussen K
    Vox Sang; 2018 Feb; 113(2):110-119. PubMed ID: 29230833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TFR2-related hereditary hemochromatosis as a frequent cause of primary iron overload in patients from Central-Southern Italy.
    Radio FC; Majore S; Binni F; Valiante M; Ricerca BM; De Bernardo C; Morrone A; Grammatico P
    Blood Cells Mol Dis; 2014; 52(2-3):83-7. PubMed ID: 24055163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
    Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
    Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of iron loading on muscle: genome-wide mRNA expression profiling in the mouse.
    Rodriguez A; Hilvo M; Kytömäki L; Fleming RE; Britton RS; Bacon BR; Parkkila S
    BMC Genomics; 2007 Oct; 8():379. PubMed ID: 17949489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron Overload (with Attention to Genetic Testing and Diagnosis/Management of HFE Wild Type Patients).
    Siddaiah N; Kowdley KV
    Curr Treat Options Gastroenterol; 2006; 9(6):447-55. PubMed ID: 17181986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron storage disease in Asia-Pacific populations: the importance of non-HFE mutations.
    McDonald CJ; Wallace DF; Crawford DH; Subramaniam VN
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1087-94. PubMed ID: 23577916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EASL clinical practice guidelines for HFE hemochromatosis.
    European Association For The Study Of The Liver
    J Hepatol; 2010 Jul; 53(1):3-22. PubMed ID: 20471131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rare types of genetic hemochromatosis.
    Camaschella C; Poggiali E
    Acta Haematol; 2009; 122(2-3):140-5. PubMed ID: 19907151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.